Abstract

We introduce a novel hybrid platform merging label free nanoplasmonic biosensing with actively controlled nanofluidic analyte delivery to overcome mass transport limitations. We show 14-fold improvement in mass transport rate constants appearing in the exponentials.

Details

Actions